Coagulation disorder
Clinical trials for Coagulation disorder explained in plain language.
Never miss a new study
Get alerted when new Coagulation disorder trials appear
Sign up with your email to follow new studies for Coagulation disorder, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to stop bleeding in emergency surgeries for blood thinner users
Disease control Recruiting nowThis Phase 3 trial tests whether a single dose of VMX-C001 can control bleeding better than usual care in 800 patients on blood thinners who need urgent high-risk surgery. Participants receive either VMX-C001 or standard treatment before their procedure, and experts will rate ble…
Matched conditions: COAGULATION DISORDER
Phase 3 • Sponsor: VarmX B.V. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New reversal agent TAK-330 aims to stop bleeding in emergency surgeries
Disease control Recruiting nowThis Phase 3 trial tests TAK-330, a drug designed to reverse the effects of common blood thinners (Factor Xa inhibitors) in patients who need urgent surgery. About 440 adults will be randomly assigned to receive TAK-330 or standard care before their procedure. The main goal is to…
Matched conditions: COAGULATION DISORDER
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New trial aims to stop deadly bleeding after birth
Disease control Recruiting nowThis study tests whether giving a clotting protein called factor XIII early can reduce blood loss in women with heavy bleeding after childbirth. About 988 women having a vaginal delivery will be randomly assigned to receive either factor XIII plus standard care or standard care a…
Matched conditions: COAGULATION DISORDER
Phase 4 • Sponsor: Christian Haslinger • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Massive study aims to crack the code on Kids' medications
Knowledge-focused Recruiting nowThis study is collecting blood and other samples from 5,000 children and young adults (under 21) who are already taking certain medications as part of their regular care. The goal is to understand how these drugs move through and affect children's bodies, so doctors can prescribe…
Matched conditions: COAGULATION DISORDER
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC